About Taisho Pharmaceutical Group
Corporate News
News
-
HoldingsJanuary 16, 2024
Finance - Notice Regarding the Results of the Tender Offer by Otemon Co., Ltd. for the Company Shares Etc. and Change of the Parent Company and the Largest Shareholder Among the Major Shareholders
-
Group CompanyJanuary 16, 2024
Products - Launch of Nanozora® 30mg Autoinjector for S.C. Injection
-
Group CompanyDecember 1, 2023
Products - Notification of the Approval of Home Self-injection Guidance and Management Fees and the Derestriction of the Dosing Period for NanozoraⓇ
-
Group CompanyAugust 1, 2023
R&D - Notification of Approval to Manufacture and Market Nanozora® 30mg Autoinjectors for S.C. Injection in Japan
-
Group CompanyJune 21, 2023
Corporate - Taisho Pharmaceutical and Biolinq Announce Strategic Collaboration and Exclusive License Agreement in Japan